Chronic opioid therapy and central sensitization in sickle cell disease

American Journal of Preventive Medicine

Volumn 51, Issue 1, 2016, Pages S69-S77

  Carroll, C Patrick ^a   Lanzkron, Sophie ^a   Haywood, Carlton ^a   Kiley, Kasey ^a   Pejsa, Megan ^a   Moscou Jackson, Gyasi ^b   Haythornthwaite, Jennifer A ^a   Campbell, Claudia M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PAIN SEVERITY; SENSITIZATION; SICKLE CELL ANEMIA; CENTRAL NERVOUS SYSTEM SENSITIZATION; PAIN MEASUREMENT; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC PAIN; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PAIN MEASUREMENT; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84975076998     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.02.012     Document Type: Article

References (75)

1. S. Moll, and E.P. Orringer Hemoglobin SC disease Am J Hematol 54 4 1997 313 10.1002/(SICI)1096-8652(199704)54:4<313::AID-AJH9>3.0.CO;2-Y
2. D.R. Powars, A. Hiti, E. Ramicone, C. Johnson, and L. Chan Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors Am J Hematol 70 3 2002 206 215 10.1002/ajh.10140
3. K. Hassell Sickle cell disease population estimation: application of available contemporary data to traditional methods [Abstract]. Paper presented at: 35th Anniversary Convention of the National Sickle Cell Disease Program; September 17-22, 2007 2007 Sickle Cell Disease Association of America Washington, DC. Baltimore 173 Abstract no.: 275
4. A. Ashley-Koch, Q. Yang, and R.S. Olney Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review Am J Epidemiol 151 9 2000 839 845 10.1093/oxfordjournals.aje.a010288
5. S.K. Ballas Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease Eur J Haematol 95 2 2015 113 123 10.1111/ejh.12460
6. S.K. Ballas, and E.D. Smith Red blood cell changes during the evolution of the sickle cell painful crisis Blood 79 8 1992 2154 2163
7. S. Charache, F.B. Barton, R.D. Moore, and et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia Medicine (Baltimore) 75 6 1996 300 326 10.1097/00005792-199611000-00002
8. Y.T. Shiu, M.M. Udden, and L.V. McIntire Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells Blood 95 10 2000 3232 3241
9. B.D. Smith, and P.L. La Celle Erythrocyte-endothelial cell adherence in sickle cell disorders Blood 68 5 1986 1050 1054
10. A. Assis, N. Conran, A.A. Canalli, I. Lorand-Metze, S.T. Saad, and F.F. Costa Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin Acta Haematol 113 2 2005 130 136 10.1159/000083451
11. L.A. Michaels, K. Ohene-Frempong, H. Zhao, and S.D. Douglas Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis Blood 92 9 1998 3148 3151
12. O.S. Platt, B.D. Thorington, D.J. Brambilla, and et al. Pain in sickle cell disease. Rates and risk factors N Engl J Med 325 1 1991 11 16 10.1056/NEJM199107043250103
13. S. Krishnan, Y. Setty, S.G. Betal, and et al. Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises Br J Haematol 148 5 2010 797 804 10.1111/j.1365-2141.2009.08013.x
14. F.A. Mohammed, N. Mahdi, M.A. Sater, K. Al-Ola, and W.Y. Almawi The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease Blood Cells Mol Dis 45 4 2010 293 296 10.1016/j.bcmd.2010.08.003
15. E. Graido-Gonzalez, J.C. Doherty, E.W. Bergreen, G. Organ, M. Telfer, and M.A. McMillen Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis Blood 92 7 1998 2551 2555
16. A.M. Brandow, C.L. Stucky, C.A. Hillery, R.G. Hoffmann, and J.A. Panepinto Patients with sickle cell disease have increased sensitivity to cold and heat Am J Hematol 88 1 2013 37 43 10.1002/ajh.23341
17. C.A. Hillery, P.C. Kerstein, D. Vilceanu, and et al. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease Blood 118 12 2011 3376 3383 10.1182/blood-2010-12-327429
18. O.S. Platt, D.J. Brambilla, W.F. Rosse, and et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death N Engl J Med 330 23 1994 1639 1644 10.1056/NEJM199406093302303
19. E.A. Lorenzi The effects of comprehensive guidelines for the care of sickle-cell patients in crisis on the nurses' knowledge base and job satisfaction for care given J Adv Nurs 18 12 1993 1923 1930 10.1046/j.1365-2648.1993.18121923.x
20. B.P. Yawn, G.R. Buchanan, A.N. Afenyi-Annan, and et al. Management of sickle cell disease JAMA 312 10 2014 1033 10.1001/jama.2014.10517
21. W.R. Smith, L.T. Penberthy, V.E. Bovbjerg, and et al. Daily assessment of pain in adults with sickle cell disease Ann Intern Med 148 2 2008 94 101 10.7326/0003-4819-148-2-200801150-00004
22. S.R. Garrison, A.A. Kramer, N.Z. Gerges, C.A. Hillery, and C.L. Stucky Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors Mol Pain 8 1 2012 62 10.1186/1744-8069-8-62
23. K.J. Zappia, S.R. Garrison, C.A. Hillery, and C.L. Stucky Cold hypersensitivity increases with age in mice with sickle cell disease Pain 155 12 2014 2476 2485 10.1016/j.pain.2014.05.030
24. Ezenwa MO, Molokie RE, Wang ZJ, et al. Safety and utility of quantitative sensory testing among adults with sickle cell disease: indicators of neuropathic pain? Pain Pract. January 12, 2015. http://dx.doi.org/10.1111/papr.12279.
25. G. Cataldo, S. Rajput, K. Gupta, and D.A. Simone Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease Pain 156 4 2015 722 730 10.1097/j.pain.0000000000000104
26. A.L. Akinyoola, I.A. Adediran, C.M. Asaleye, and A.R. Bolarinwa Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease Int Orthop 33 4 2009 923 926 10.1007/s00264-008-0584-1
27. M.A. Mont, M.G. Zywiel, D.R. Marker, M.S. McGrath, and R.E. Delanois The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review J Bone Joint Surg Am 92 12 2010 2165 2170 10.2106/JBJS.I.00575
28. R. Chou, G.J. Fanciullo, P.G. Fine, and et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain J Pain 10 2 2009 113 130 10.1016/j.jpain.2008.10.008
29. R. Chou, J.C. Ballantyne, G.J. Fanciullo, P.G. Fine, and C. Miaskowski Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline J Pain Off J Am Pain Soc 10 2 2009 147 159 10.1016/j.jpain.2008.10.007
30. E. Kalso, J.E. Edwards, R.A. Moore, and H.J. McQuay Opioids in chronic non-cancer pain: systematic review of efficacy and safety Pain 112 3 2004 372 380 10.1016/j.pain.2004.09.019
31. J.O. Merrill, M. Von Korff, C.J. Banta-Green, and et al. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients Gen Hosp Psychiatry 34 6 2012 581 587 10.1016/j.genhosppsych.2012.06.018
32. M.D. Sullivan, M. Von Korff, C. Banta-Green, J.O. Merrill, and K. Saunders Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain Pain 149 2 2010 345 353 10.1016/j.pain.2010.02.037
33. M. Choinière, D. Dion, P. Peng, and et al. The Canadian STOP-PAIN project - Part 1: who are the patients on the waitlists of multidisciplinary pain treatment facilities? Can J Anaesth 57 6 2010 539 548 10.1007/s12630-010-9305-5
34. I.A. Strigo, A.N. Simmons, S.C. Matthews, A.D.B. Craig, and M.P. Paulus Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain Arch Gen Psychiatry 65 11 2008 1275 1284 10.1001/archpsyc.65.11.1275
35. T. Giesecke, R.H. Gracely, D.A. Williams, M.E. Geisser, F.W. Petzke, and D.J. Clauw The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort Arthritis Rheum 52 5 2005 1577 1584 10.1002/art.21008
36. I.A. Strigo, A.N. Simmons, S.C. Matthews, A.D.B. Craig, and M.P. Paulus Increased affective bias revealed using experimental graded heat stimuli in young depressed adults: evidence of "emotional allodynia Psychosom Med 70 3 2008 338 344 10.1097/PSY.0b013e3181656a48
37. K. Hagen, C. Albretsen, S.T. Vilming, and et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial Cephalalgia 29 2 2009 221 232 10.1111/j.1468-2982.2008.01711.x
38. J.R. Saper, and A.E. Lake 3rd Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines Headache 48 6 2008 838 849 10.1111/j.1526-4610.2008.01153.x
39. M. De Felice, and F. Porreca Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache Cephalalgia 29 12 2009 1277 1284 10.1111/j.1468-2982.2009.01873.x
40. C.O. Townsend, J.L. Kerkvliet, B.K. Bruce, and et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission Pain 140 1 2008 177 189 10.1016/j.pain.2008.08.005
41. J.L. Murphy, M.E. Clark, and E. Banou Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment Clin J Pain 29 2 2013 109 117 10.1097/AJP.0b013e3182579935
42. R.A. Crisostomo, J.E. Schmidt, W.M. Hooten, J.L. Kerkvliet, C.O. Townsend, and B.K. Bruce Withdrawal of analgesic medication for chronic low-back pain patients: improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history Am J Phys Med Rehabil 87 7 2008 527 536 10.1097/PHM.0b013e31817c124f
43. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med. 8(1):8-16. 10.1111/j.1526-4637.2007.00253.x.
44. L.F. Chu, D.J. Clark, and M.S. Angst Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study J Pain 7 1 2006 43 48 10.1016/j.jpain.2005.08.001
45. L. Chen, C. Malarick, L. Seefeld, S. Wang, M. Houghton, and J. Mao Altered quantitative sensory testing outcome in subjects with opioid therapy Pain 143 1-2 2009 65 70 10.1016/j.pain.2009.01.022
46. S.K. Ballas, K. Gupta, and P. Adams-Graves Sickle cell pain: a critical reappraisal Blood 120 18 2012 3647 3656 10.1182/blood-2012-04-383430
47. D. Pud, D. Cohen, E. Lawental, and E. Eisenberg Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects Drug Alcohol Depend 82 3 2006 218 223 10.1016/j.drugalcdep.2005.09.007
48. K.C. Ram, E. Eisenberg, M. Haddad, and D. Pud Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain - new perspective of opioid-induced hyperalgesia Pain 139 2 2008 431 438 10.1016/j.pain.2008.05.015
49. J.L. Hay, J.M. White, F. Bochner, A.A. Somogyi, T.J. Semple, and B. Rounsefell Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients J Pain 10 3 2009 316 322 10.1016/j.jpain.2008.10.003
50. J.L. Hay, J. Kaboutari, J.M. White, A. Salem, and R. Irvine Model of methadone-induced hyperalgesia in rats and effect of memantine Eur J Pharmacol 626 2-3 2010 229 233 10.1016/j.ejphar.2009.09.056
51. S.P. Cohen, P.J. Christo, S. Wang, and et al. The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus Reg Anesth Pain Med 33 3 2008 199 206 10.1016/j.rapm.2007.10.009
52. J.M. Prosser, M. Steinfeld, L.J. Cohen, and et al. Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance Drug Alcohol Depend 95 3 2008 237 244 10.1016/j.drugalcdep.2008.01.012
53. J. Sandkühler, and R. Ruscheweyh Opioids and central sensitisation: I. Preemptive analgesia Eur J Pain 9 2 2005 145 148 10.1016/j.ejpain.2004.05.012
54. R. Ruscheweyh, and J. Sandkühler Opioids and central sensitisation: II. Induction and reversal of hyperalgesia Eur J Pain 9 2 2005 149 152 10.1016/j.ejpain.2004.05.011
55. E.M. Andresen, J.A. Malmgren, W.B. Carter, and D.L. Patrick Screening for depression in well older adults: evaluation of a short form of the CES-D Am J Prev Med 10 2 1994 77 84
56. J.J. Wison Schaeffer, K.M. Gil, M. Burchinal, and et al. Depression, disease severity, and sickle cell disease J Behav Med 22 2 1999 115 126 10.1023/A:1018755831101
57. S.F. Butler, S.H. Budman, K.C. Fernandez, and et al. Development and validation of the Current Opioid Misuse Measure Pain 130 1-2 2007 144 156 10.1016/j.pain.2007.01.014
58. S.F. Butler, S.H. Budman, G.J. Fanciullo, and R.N. Jamison Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy Clin J Pain 26 9 2010 770 776 10.1097/AJP.0b013e3181f195ba
59. E.C. Meltzer, D. Rybin, R. Saitz, and et al. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM) Pain 152 2 2011 397 402 10.1016/j.pain.2010.11.006
60. C.J. Woolf Central sensitization: implications for the diagnosis and treatment of pain Pain 152 3)(suppl 2011 S2 S15 10.1016/j.pain.2010.09.030
61. L. Diatchenko, A.G. Nackley, G.D. Slade, R.B. Fillingim, and W. Maixner Idiopathic pain disorders - pathways of vulnerability Pain 123 3 2006 226 230 10.1016/j.pain.2006.04.015
62. C.M. Campbell, L.F. Buenaver, P. Finan, and et al. Sleep, pain catastrophizing, and central sensitization in knee osteoarthritis patients with and without insomnia Arthritis Care Res (Hoboken) 67 10 2015 1387 1396 10.1002/acr.22609
63. Hayes AF. PROCESS: a versatile computational tool for observed variable mediation, moderation, and conditional process modeling. www.afhayes.com. Published 2012.
64. P.O. Johnson, and L.C. Fay The Johnson-Neyman technique, its theory and application Psychometrika 15 4 1950 349 367 10.1007/BF02288864
65. M. Von Korff, A. Kolodny, R.A. Deyo, and R. Chou Long-term opioid therapy reconsidered Ann Intern Med 155 5 2011 325 328 10.7326/0003-4819-155-5-201109060-00011
66. E. Celerier, C. Rivat, Y. Jun, and et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine Anesthesiology 92 2 2000 465 472
67. E. Celerier, J.P. Laulin, J.B. Corcuff, M. Le Moal, and G. Simonnet Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process J Neurosci 21 11 2001 4074 4080
68. E. Celerier, J. Laulin, A. Larcher, M. Le Moal, and G. Simonnet Evidence for opiate-activated NMDA processes masking opiate analgesia in rats Brain Res 847 1 1999 18 25
69. J.P. Laulin, A. Larcher, E. Celerier, M. Le Moal, and G. Simonnet Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time Eur J Neurosci 10 2 1998 782 785
70. W. Koppert, R. Sittl, K. Scheuber, M. Alsheimer, M. Schmelz, and J. Schüttler Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans Anesthesiology 99 1 2003 152 159
71. H. Wang, M. Akbar, N. Weinsheimer, S. Gantz, and M. Schiltenwolf Longitudinal observation of changes in pain sensitivity during opioid tapering in patients with chronic low-back pain Pain Med 12 12 2011 1720 1726 10.1111/j.1526-4637.2011.01276.x
72. L.M. Carcoba, A.E. Contreras, A. Cepeda-Benito, and M.W. Meagher Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals J Addict Dis 30 3 2011 258 270 10.1080/10550887.2011.581985
73. G.F. Gebhart Descending modulation of pain Neurosci Biobehav Rev 27 8 2004 729 737 10.1016/j.neubiorev.2003.11.008
74. A.D. Furlan, J.a. Sandoval, A. Mailis-Gagnon, and E. Tunks Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects CMAJ 174 11 2006 1589 1594 10.1503/cmaj.051528
75. N.I. Cherny, H.T. Thaler, H. Friedlander-Klar, and et al. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies Neurology 44 5 1994 857 10.1212/WNL.44.5.857